GlassScriptPhysician profile
Brittany S Fuller
NPI 1538426267
$61,369.59
in general payments reported to CMS, 2019-2025
16 companies · $2,237 in 2025
The $2,237 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $59.01 · 2021: $133 · 2022: $6,474 · 2023: $24K · 2024: $28K · 2025: $2,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Consulting Fee: $9,900 · Honoraria: $7,850 · Food and Beverage: $1,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $22,198.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,690.00 |
| Consulting Fee | $9,900.00 |
| Honoraria | $7,850.00 |
| Food and Beverage | $1,648.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $42,237.57 | 2021-2024 | (9520) Igt Devices Undivided, (7881) US Und, (Bh4) Igt Devices Undivided |
| Pfizer INC. | $12,690.00 | 2023 | |
| Abbott Laboratories | $2,459.67 | 2019-2025 | Xience V, Optis, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,000.00 | 2025 | Lifevest |
| Abiomed | $769.41 | 2022-2025 | Impella |
| Inari Medical, INC. | $634.10 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $136.12 | 2019 | |
| Boston Scientific Corporation | $108.76 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $85.95 | 2022 | |
| Amgen INC. | $67.94 | 2021-2023 | Repatha |
| Kestra Medical Technology Services, INC. | $54.25 | 2024 | Assure Wcd |
| Edwards Lifesciences Corporation | $49.74 | 2021 | |
| Teleflex LLC | $47.76 | 2020-2023 | Guideliner |
| Medline Industries LP | $17.14 | 2022 | |
| Shockwave Medical, INC | $11.18 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.